Nanomedicine and HIV symposium programme (Draft)
DAY 1
3rd SA-SWISS NANO TB & HIV/AIDS 2017
SA –SWISS NANOMEDICINE SYMPOSIUM ON TB & HIV/AIDS
Venue: CSIR ICC, Ruby Auditorium, Pretoria
Date: 05 and 06 December 2017; Time: 08:30-17:00.
| DAY 1: 3rd NANOMEDICINE AND HIV/AIDS SYMPOSIUM | ||
| 08:00-08:50 | Arrival and Registration | |
| Programme Facilitator: Dr Mthuthuzeli Zamxaka, SAASTA | ||
| Time | Activity | Presenter |
| 09:00-09:10 | Brief background of the symposium | Dr Mthuthuzeli Zamxaka, SAASTA |
| 09:10-09:25 | NRF contributions to TB and HIV/AIDS research in South Africa | Dr Beverley Damonse, NRF |
| 09:25-09:40 | Address by Swiss Ambassador | Ms Helene Budliger Artieda, Swiss |
| 09:40-09:55 | The current situation of TB and HIV/AIDS in South Africa | Mr David Mametja, NDoH |
| 09:55-10:20 | Panel discussion | ALL |
| 10:20-10:40 | Tea Break and Exhibition | |
| Session Title: Policy Context for Utilisation of Nanomedicine in the Health sector
Session Objectives: Understanding the policy environment for nanomedicine and its relevance to the health sector in South Africa Programme Facilitator: Dr Beverley Damonse, NRF |
||
| 10:40-10:55 | Accelerating access to cheaper, better medicines using South African unique infrastructure | Prof Francois Venter, Wits |
| 10:55-11:10 | The present and future projection of the use of Nanotechnology in solving global 21st challenges | Prof Malik Maaza, UNISA |
| 11:10-11:25 | Nanotechnology: Research and postgraduate funding | Dr Rakeshnie Ramoutar-Prieschl, NRF |
| 11:25- 11:45 | Panel discussion | All |
| Session Title: Nanomedicine and HIV/AIDS
Session Objective: Showcasing cutting-edge nanomedicine in HIV/AID research Programme Facilitator: Dr Admire Dube, UWC |
||
| 11:45-12:00 | Swiss-South Africa: HIV drug discovery researcher | Dr Vinesh Maharaj, CSIR
Prof Thomas Klimkait, UNIBAS |
| 12:00-12:15 | Biological nanoparticles for the delivery of antibodies against HIV | Dr Fiona van den Berg, NICD |
| 12:15-12:30 | Nanotherapeutics for the selective induction of apoptosis in targeted HIV infected cells | Prof Mervin Meyer, UWC |
| 12:30-12:45 | Towards TB and HIV/AIDS diagnostic: A dendrimer-streptavidin supramolecular nano-architecture for electrochemical biosensor development | Prof Omotayo Arotiba, UJ |
| 12:45-13:10 | Panel discussion | ALL |
| 13:10-14:10 | Lunch Break and Exhibition | |
| Session Title: Health Innovation
Session Objective: To highlight opportunities provided by SA and Swiss Embassy towards innovation support Programme Facilitator: Dr Steven Mufamadi, Nabio Consulting |
||
| 14:10-14:35 | Health Innovation: DST strategy | Dr Glaudina Loots, DST |
| 14:35-14:50 | Swiss innovation challenge | Mr Davis Cook, RIIS |
| 14:50-15:05 | Novartis and University of Basel Next Generation Scientist (NGS) programme | Ms Akiko Keller, Novartis |
| 15:05-15:30 | Panel discussion | ALL |
| 15:30-15:45 | Tea Break and Exhibition | |
| Session Title:Pre-Clinical and Clinical Research Skills Shortage Session Objective: SA and Swiss pre-clinical and clinical research skills programmes Programme Facilitator:Prof Mervin Meyer,UWC |
||
| 15:45-16:00 | Pre-clinical and clinical development for nanopharmaceutics | Prof Rose Hayeshi, NWU |
| 16:00-16:15 | HIV epitopes as candidates for drug and vaccine development | Wolf-DieterSchubert, UP |
| Engagement Session: Take Home Messages Session Objectives: To highlight key messages and way forward from all the panel discussions Programme Facilitator: Mr Michael Ellis, SAASTA |
||
| 16:15-16:50 | Panel discussion: Symposium summary, key ideas and future developments (Audience engagement through digital platform) |
Panel: – One key speaker from each of the above sessions |
| 16:50-17:00 | Vote of thanks and announcement | Ms Katlego Mokomo, Swiss |
| 18:30-22:00 | Cocktail & networking platform | Swiss- SA Ambassador’s House |
DAY 2
| DAY 2: 1ST TB NANOMEDICINE SYMPOSIUM | |||
| Programme Facilitator: Dr Mthuthuzeli Zamxaka, SAASTA | |||
| 09:00-09:15 | Technology Innovation & commercialisation support: Swiss-South Africa Business Development Programme (SSABDP) | Ms Karen Eksteen, TIA | |
| 09:15-09:30 | The Global Burden of TB and HIV/AIDS | Dr Rufaro Chatora, WHO | |
| 09:30-09:45 | Nanotechnology research and innovation: Swiss perspective | Prof Edwin Constable, UNIBAS | |
| 09:45-10:10 | Panel Discussion | ALL | |
| 10:10 -10:30 Tea Break and Exhibition | |||
| Session Title: Nanomedicine and TB
Session Objectives: Showcasing cutting-edge nanomedicine in TB research Programme Facilitator: Dr Boitumelo Semete-Makokotlela, CSIR |
|||
| 10:30-10:45 | Nanoparticle based immunotherapy for TB treatment | Dr Admire Dube, UWC | |
| 10:45-11:00 | Inhalable nanomedicine – Pulmonary delivery of anti-TB drugs using pH responsive carriers | Mr Mpho Ngoepe, Rhodes | |
| 11:00-11:15 | Nanomedicine Training during Novartis and University of Basel next generation programme | Dr Phuti Chelopo, CSIR | |
| 11:15 -11:50 | Panel discussion | ALL | |
| Session Title: Manufacturing and Commercialisation of Nanomaterials
Session Objectives: Nanomedicine manufacturing and commercialization supporting programme Programme Facilitator: Dr Sibongile Gumbi, iVacBio |
|||
| 11:50-12:05 | Amnis Imaging cytometry in the nanotechnology manufacturing | Dr John Walters, Merck | |
| 12:05-12:20 | Entrepreneurs as the catalyst of nanomedicine commercialization | Dr Steven Mufamadi, Nabio Consulting | |
| 12:20-12:35 | DTI Perspective (Investments in Commercialising Innovative Research) | Ms Nontombi Marule, TheDTI | |
| 12:35-13:00 | Panel discussion | ALL | |
| 13:00-14:00 Lunch Break and Exhibition | |||
| Session Title: Nanosafety Issues and Private Sector Session Objective: Understanding of the hazards of nanomaterials in health and private sector in TB and HIV/AIDS Programme Facilitator: Dr Patric Nkuna, CSIR |
|||
| 14:00-14:15 | ACGT Health Biotechnology: TB and HIV/AIDS programmes | Wolf-DieterSchubert, UP | |
| 14:15-14:30 | Swiss private sector: Roche activities in South Africa | Dr Nick Mangeya, Roche | |
| 14:30-14:45 | ARV drug developed and manufactured in Africa | Mr Stavros Nicolaou, Aspen | |
| 14:45-15:15 | Panel discussion | ALL | |
| 15:15-15:35 Tea Break and Exhibition | |||
| Session: Media and Public Engagement
Engagement Session: Take Home Messages Session Objectives: To highlight key messages and way forward from all the panel discussions Programme Facilitator: Mr Michael Ellis, SAASTA |
|||
| 15:35-15:50 | Nanoscience education and public engagement platforms | Mr Robert Inglis, JM | |
| 15:50-16:05 | Science journalism | Ms Ntando Makhuba, The Star news | |
| 16:05-16:45 | Panel discussion: Symposium summary, key ideas and future developments
(Audience engagement through digital platform) |
Panel: One key speaker from each of the above sessions | |
| 16:45-16:55 | Summary | Prof Edwin Constable, Swiss | |
| 16:55-17:00 | Vote of thanks and announcement | Ms Jacquelene Friedenthal, Swiss | |